STAT3 a Moonlighting Protein: Focus on Its Post-translational Modifications and Protein Interactors
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".
Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 5456
Special Issue Editors
Interests: STAT3; carcinogenesis;transduction signalling pathways; biochemistry OCPs environmental pollutants
Special Issues, Collections and Topics in MDPI journals
Interests: cancer biology; stat3; signal transduction; chemoresistance; immunotherapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The signal transducer and activator of transcription 3 (STAT3) is a protein with polyhedral activities: it mediates, directly or indirectly, multiple cellular signaling pathways (cytokines of growth factors, hormones and oxidative stress). In addition, it is a key protein in the modulation of metabolism and mitochondrial activity and it is involved in the regulation of microtubule dynamics in the cellular cytoskeleton.
STAT3 activation is crucial in various diseases such as chronic inflammation, cardiovascular and metabolic disorders and cancer. In fact, many scientific publications have assessed the involvement of STAT3, through both its canonical and non-canonical pathways, in all three phases of carcinogenesis: initiation, progression and invasion. STAT3 can be considered a moonlighting protein and its multifaceted activities are mainly exerted via post-translational modifications such as phosphorylation, acetylation, glutathionylation and methylation and interaction with a variety of protein components.
This Special Issue aims to investigate the key role of STAT3, its PTMs and its protein ligands in the modulation of cellular functions. Moreover, this Special Issue should provide a broad and accurate account of STAT3’s cellular and biological functions; we hope that researchers in the field will contribute with research articles, review articles, innovative hypotheses or commentaries on STAT3-related activities and regulations.
Dr. Margherita Eufemi
Guest Editor
Dr. Donatella Romaniello
Co-Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- STAT3
- signaling pathways
- post-translational modifications
- interactors
- energy and cellular metabolism
- cancer
